Core Laboratories Reports Q3 2026 Revenue Growth and Margin Expansion
Core Laboratories (CLB) reported third-quarter 2026 results characterized by sequential revenue growth of 6% to $132.1 million, driven primarily by increased demand for completion products and international laboratory services. The company saw a significant boost in Non-GAAP operating income, which rose 35% from the previous quarter to $12.6 million, reflecting improved operational efficiency and higher revenue absorption. Despite strong performance in U.S. product sales and reservoir description services, geopolitical instability in the Middle East and Russia created headwinds for certain international projects. Management provided Q4 2026 revenue guidance between $128.5 million and $134.5 million, anticipating relatively flat sequential performance due to ongoing project delays caused by maritime transportation disruptions.
Tickers: $CLB
Topics: EPS Free Cash Flow Operating Income Revenue Growth Segment Performance